Manulife strengthens cooperation with CUHK Medical Centre to incorporate fragmented technology into treatment options
Manulife has strengthened its cooperation with The Chinese University of Hong Kong (CUHK) Medical Centre to incorporate fragmentation technology into its health insurance plans, providing innovative therapies for cancer patients. This technology is an FDA-approved non-invasive treatment aimed at providing efficient options for liver cancer patients. The service will be implemented once the technology is available to the public, and patients will need to participate in clinical trials to monitor outcomes. Manulife has established a partnership with CUHK Medical Centre since 2021 to provide medical consultation and pre-approval services without co-payment
Manulife strengthens cooperation with CUHK Medical Centre to incorporate tissue fragmentation technology into treatment options
Manulife announced the strengthening of its strategic partnership with the Chinese University of Hong Kong Medical Centre, incorporating the innovative tissue fragmentation technology into its comprehensive "Healthcare Specialist Support Service" designed for clients with confirmed or suspected cancer under Manulife's designated medical insurance plans. This service will commence once the tissue fragmentation technology becomes available for public use at CUHK Medical Centre, at which point relevant patients will need to participate in clinical trials for close monitoring and evaluation of clinical outcomes.
Tissue fragmentation technology is an FDA-approved technique that provides a non-invasive, painless, and efficient treatment option for liver cancer patients. The Li Ka Shing Foundation previously introduced this treatment technology to medical institutions in Hong Kong through donations. The coverage for all Manulife medical insurance plan clients includes tissue fragmentation technology, further enhancing protection for clients.
In 2021, Manulife established a strategic partnership with CUHK Medical Centre to offer eligible clients a free personal medical consultation. Subsequently, in 2023, both parties further expanded their cooperation, with Manulife providing pre-approval services for over 300 all-inclusive medical packages offered by the hospital, including endoscopic examination procedures and surgical procedures
